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Background: Age-related frailty is a multidimensional dynamic condition associated with adverse patient outcomes
and high costs for health systems. Several interventions have been proposed to tackle frailty. This correspondence
article describes the journey through the development of evidence- and consensus-based guidelines on interventions
aimed at preventing, delaying or reversing frailty in the context of the FOCUS (Frailty Management Optimisation
through EIP-AHA Commitments and Utilisation of Stakeholders Input) project (664367-FOCUS-HP-PJ-2014). The
rationale, framework, processes and content of the guidelines are described.
Main text: The guidelines were framed into four questions – one general and three on specific groups of interventions –
all including frailty as the primary outcome of interest. Quantitative and qualitative studies and reviews conducted in the
context of the FOCUS project represented the evidence base. We followed the GRADE Evidence-to-Decision frameworks
based on assessment of whether the problem is a priority, the magnitude of the desirable and undesirable effects, the
certainty of the evidence, stakeholders’ values, the balance between desirable and undesirable effects, the resource use,
and other factors like acceptability and feasibility. Experts in the FOCUS consortium acted as panellists in the consensus
process. Overall, we eventually recommended interventions intended to affect frailty as well as its course and related
outcomes. Specifically, we recommended (1) physical activity programmes or nutritional interventions or a combination
of both; (2) interventions based on tailored care and/or geriatric evaluation and management; and (3) interventions based
on cognitive training (alone or in combination with exercise and nutritional supplementation). The panel did not support
interventions based on hormone treatments or problem-solving therapy. However, all our recommendations were weak
(provisional) due to the limited available evidence and based on heterogeneous studies of limited quality. Furthermore,
they are conditional to the consideration of participant-, organisational- and contextual/cultural-related facilitators or
barriers. There is insufficient evidence in favour of or against other types of interventions.
Conclusions: We provided guidelines based on quantitative and qualitative evidence, adopting methodological
standards, and integrating relevant stakeholders’ inputs and perspectives. We identified the need for further studies of a
higher methodological quality to explore interventions with the potential to affect frailty.
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Frailty and its impact
The term ‘frailty’ has been used to describe an age-
related state of decline and vulnerability characterised by
weakness and decreased physiological reserve [1]. Frail
older adults are less able to adapt to stressors such as
acute illness, surgery, trauma or bereavement, and are at
increased risk of falls, institutionalisation, disability and
death [2, 3]. The concept of frailty has been operationa-
lised through different definitions to help clinicians, re-
searchers and other stakeholders to identify frail older
patients. One of the most commonly adopted definitions
is the one used in the Cardiovascular Health Study,
known as the Frailty Phenotype or Physical Frailty. It is
based on five criteria related to reduced physical reserve,
and defines frail and prefrail states based on the number
of criteria met [1]. Others sustain a different approach,
which views frailty as a multidimensional risk state de-
fined by the accumulation of deficits in different do-
mains, such as cognition and mood, chronic diseases,
polypharmacy, functional autonomy and social condi-
tions, using a continuous scale as opposed to category
assignment. The Frailty Index by Rockwood et al. [4] is
taken as a paradigm of this second approach.
Although the use of different definitions leads to the
identification of different target populations and leads to
a variation in the estimate of the actual prevalence ofTable 1 The FOCUS evidence base and its relevance in the assessm
Decision (EtD) criteria
FOCUS project deliverablesa Evidence type
Systematic review of the effectiveness of
interventions on frailty (D4.1.2) [11]
Quantitative: A systematic review
interventions on frailty in older p
economy studies
Review of qualitative studies on frailty
interventions with stakeholders
(D4.1.3) [12]
Qualitative: A meta-synthesis of
stakeholders’ views and experien
interventions in the context of f
Thematic summary of focus groups with
stakeholders in three different EU states
(D4.1.4) [13]
Qualitative: An inductive themat
focus groups and individual inte
countries (Italy, Poland, UK) with
including frail and non-frail olde
and health and social care profe
Thematic summary of joint focus groups
with EU policy-makers (D4.1.5) [14]
Qualitative: An inductive themat
interviews with seven healthcare
Structured survey of partners within the
EIP-AHA (D4.1.7) [15]
Mixed: A structured survey seeki
partners
Realist review (D4.1.8) [16] Mixed: A realist review combinin
components to examine what w
what circumstances
Comprehensive report of the results of the
comparative analyses and modelling
(FOCUS internal deliverable D5.2.1–5)
Quantitative: Comparative analy
upon structure, process and out
analyses of significant predictors
care needs and use in the frame
of changes in frailty as a result o
EIP-AHA European Innovation Partnership on Active and Healthy Aging, EU Europea
aDeliverables are enumerated and titled based on FOCUS Grant Agreementfrailty [5, 6], the associations between frailty, adverse
outcomes, and health and social care utilisation have
been invariably demonstrated. This has been common
understanding for more than a decade [7] and has led to
several initiatives to tackle frailty and its related
outcomes.
The FOCUS project
To add to the international efforts to reduce the impact of
frailty, we conducted the FOCUS (Frailty Management Op-
timisation through EIP-AHA Commitments and Utilisation
of Stakeholders Input) project, funded by the European
Union’s Third Health Programme (2014–2020) [8, 9]. The
project included a series of quantitative and qualitative
studies [10–16] (Table 1), which, through the review and
appraisal of the literature and the collection of stakeholder
inputs, served the project mission of providing instruments
to guide the implementation and scaling up of effective
strategies of frailty prevention and management. The devel-
opment of clinical guidelines represented an ultimate im-
portant achievement in the fulfilment of this mission.
The need for clinical guidelines
At the time of designing our project, we recognised the
need to offer patients, their formal and informal carers,
healthcare practitioners, and decision-makers a scientific
support to their actions, by bringing together scientificent of interventions targeting frailty based on the Evidence-to-
EtD criteria for which the evidence
was considered relevant
of randomised studies on
eople, including health
Benefits, harms, resource use, cost-
effectiveness, equity
qualitative studies on
ces of care and
railty
Outcome importance, value, equity,
acceptability, feasibility
ic analysis of semi-structured
rviews in three European
five groups of stakeholders,
r adults, family caregivers,
ssionals
Outcome importance, value, equity,
acceptability, feasibility
ic analysis of semi-structured
policy-makers across Europe
Outcome importance, value, equity,
acceptability, feasibility
ng the opinions of EIP-AHA Outcome importance, value, equity,
acceptability, feasibility
g findings from the different
orks, for whom and in
Outcome importance, value, equity,
acceptability, feasibility
ses of EIP-AHA commitments
come indicators; modelling
of outcome, health and social
of frailty, with projected impact
f interventions
Resource use and feasibility (additional
considerations)
n Union
Table 2 FOCUS guideline questions in the PICO format
GQ – Should interventions to prevent or delay the progression of frailty,
or to reverse frailty, be adopted in prefrail or frail older people?
Q1 – Should physical interventions be recommended to prevent or
delay the progression of frailty, or to reverse frailty, in prefrail or
frail older people?
Q2 – Should interventions based on tailored care and/or GEM be
recommended to prevent or delay the progression of frailty, or to
reverse frailty, in prefrail or frail older people?
Q3 – Should other interventions be recommended to prevent or delay
the progression of frailty, or to reverse frailty, in prefrail or frail
older people?
Patients: People aged 65 years or older, defined as prefrail or frail
according to a pre-specified scale, index or criteria, not at the end-of-life
phase or selected because of an index disease
Interventions:
GQ: Any intervention explicitly defined as an intervention for frailty
(regardless of the definition of frailty used)
Q1: Physical interventions
• Interventions based on exercise/physical activity
• Nutritional interventions (e.g. diet change, supplementation)
• Exercise/physical activity combined with nutritional interventions
Q2: Interventions based on tailored care and/or GEM
• Uni-professional interventions based on tailored care/GEM
• Multidisciplinary interventions based on tailored care/GEM
Q3: Other interventionsa
• Cognitive training
• A composite of exercise + nutritional supplementation + cognitive
training
• Exercise + nutritional consultation
• Problem-solving therapy
• Hormone therapy
• Others
Reference intervention: No intervention or placebo or usual care
Outcomes:
• Frailty – defined according to a composite index, or based on
physical performance tests commonly related to the ‘frailty’
definition (SPPB, TUG, gait speed, handgrip strength)
• Other relevant patient important outcomes – cognitive performance,
functional performance, other measures of physical performance,
quality of life, depression, self-perceived health, social engagement,
caregiver burden, falls and fractures, mortality, hospitalisation, institu-
tionalisation, comorbidity burden, drug prescription
Setting: Any (community, primary care, nursing homes, hospitals)
Perspective: Population
GEM geriatric evaluation and management, GQ general question, Q question,
SPPB short physical performance battery, TUG time up and go
aThe provided list of interventions includes interventions evaluated in studies
found in our systematic review [12] that did not match Q1 and Q2 definitions;
it does not include any other possible intervention
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dations that responded to the definition of clinical
guidelines [17, 18]. In fact, as the interest in the concept
of frailty had also grown outside the internal and geriat-
ric medicine field, we had seen several non-geriatric sci-
entific societies including special considerations on the
management of the disease(s) of interest related to older
frail patients in their clinical guidelines [19–22]. How-
ever, within the specific field of frailty as a syndrome,
when the FOCUS consortium started its work in 2015,
there were no clinical guidelines generated from rigor-
ous methods recognised as standards by the scientific
community, which would give frailty the dignity of other
clinical conditions [23]. Therefore, we translated our
FOCUS project mission into the development of evi-
dence- and consensus-based guidelines, intended for all
those involved in decision-making and implementation
of actions on frailty.
This correspondence article presents the development
process of our FOCUS guidelines, providing their justifi-
cation, with emphasis on their novelty, limitations and
implications.
Main text
Definition of the clinical questions: frailty as an outcome
We started by formulating the questions to be an-
swered by the guidelines, based on the PICO format
[24] (Table 2). While the project covered the entire
spectrum of relevant clinical questions on frailty, in-
cluding screening and diagnostic strategies [10], we
decided to focus the guidelines on the role of interven-
tions to prevent, delay or revert frailty. We framed the
guidelines according to a hierarchical structure. We
included a first question (General Question, GQ) ask-
ing whether the overall current evidence and stake-
holder inputs support interventions meant to affect
frailty and its course, followed by the addition of sub-
questions (Questions 1–3 (Q1–Q3)) focused on spe-
cific types of interventions. For each question, two
population subgroups were also considered, i.e. frail
and prefrail subjects. The choice of the outcome and
its definition represented the most sensitive step in
the formulation of our PICO questions. We prespeci-
fied ‘frailty’ as our primary outcome, in compliance
with the FOCUS project mission and the intention to
treat frailty as a syndrome; we reflected the choice
previously made in the definition of the study inclu-
sion criteria for our systematic review of randomised
controlled trials on interventions to prevent or reduce
frailty [11]. Specifically, in our systematic review, we
included studies that looked at the effect of interven-
tions on frailty defined according to any validated
scale, index, indicator or sets of indicators that were
explicitly adopted by the authors as a definition forfrailty [11]. However, our systematic review and guide-
lines also considered and evaluated the effect on
frailty-related outcomes, which we defined as our sec-
ondary outcomes, including cognitive performance,
ability to perform activities of daily life and quality of
life, among others [11].
Selection of a framework: GRADE and Evidence-to-
Decision
We adopted the GRADE (Grading of Recommendations
Assessment, Development and Evaluation) Working
Group system to assess the certainty of evidence and de-
fine the strength of related recommendations [25, 26]. In
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framework, which was developed by the GRADE Work-
ing Group to support the process of moving from evi-
dence to decisions, in the contexts of making clinical
recommendations or coverage, health system, or public
health decisions [27]. It has been implemented as an
interactive online tool (iEtD) that can support a
consensus-based process, which we used [28]. The
framework suggests a list of criteria upon which the in-
tervention(s) of interest should be assessed based on re-
search evidence, namely whether the problem is a
priority, the magnitude of the desirable and undesirable
effects, the certainty of the evidence, how patients (or
others affected, such as carers) value the main outcomes,
the balance between desirable and undesirable effects,
resource use, acceptability, and feasibility [27].
FOCUS evidence base
The development of our guidelines was preceded by a
series of quantitative and qualitative studies performed
within the FOCUS project, reported in separate publica-
tions [11–16], which represented the evidence base for
our judgments and recommendations. In particular, we
performed a systematic review of randomised controlled
trials evaluating interventions on frailty, which repre-
sented our quantitative evidence base [11]. As a support
to the consensus process, the relevant results of the sys-
tematic review were synthesised into tables, one for each
of the sub-questions (Additional file 1). The tables focused
on the effect of interventions on frailty as an outcome, ac-
cording to different frailty definitions and based on the
typical GRADE Summary of Findings table structure [25].
The effect of interventions on the secondary outcomes
was narratively synthesised (Additional file 2). We also
performed a realist review [16], using the approach of the
Realist and Meta-narrative Evidence Synthesis: EvolvingFig. 1 Steps of the FOCUS guideline development processStandards (RAMESES) project [29] and integrating the re-
sults of the systematic review with other FOCUS studies,
to try to respond to the question “what works, for whom
and in what circumstances’; this realist review represented
the base for our recommendations on implementation (i.e.
the conditions for the intervention to succeed). These and
the other FOCUS studies are listed in Table 1, together
with their relevance to the EtD criteria used to develop
these guidelines.
Consensus process
The guideline panel included the FOCUS project investi-
gators with a background in health and social sciences
as well as expertise in frailty, aging and health research
methods. Most of them are members of the European
Innovation Partnership on Active and Healthy Ageing
(EIP-AHA) [30]. Table S1 in the Additional file 3: Table
S1 lists the FOCUS investigators, their professional pro-
file and their role in guideline development. We under-
took a multistep approach, as schematised in Fig. 1. The
technical team (Table S1) conducted a preliminary ap-
praisal of the evidence base upon the iEtD criteria and
submitted it to the panel using the iEtD tool. The panel
was asked to revise this appraisal and to make their
judgment on the existing evidence for each question,
upon each criterion. In particular, the judgement was
guided by criterion-specific questions (e.g. ‘How sub-
stantial are the desirable anticipated effects?’) that the
panel had to answer using an ordinal scale. Voting was
anonymous. Panel discussion was also encouraged via
email. The technical team collated the panel’s judgments
and comments. A draft consensus judgement for each
criterion and for each question was determined based on
the mode and median rating. Any non-coincidence be-
tween mode and median rating was considered semi-
quantitative proof of skewness of the votes, suggesting
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and median coincided, a note (e.g. ‘+’ or ‘–’) was added
to the draft consensus statement in the case of signifi-
cant heterogeneity in the vote distribution.
Of the 13 FOCUS project investigators who were given
the role of voting panellists, 11 participated in the voting
process. All criteria for all questions were covered by the
voting, but with a few missing votes, which were evenly
distributed across criteria and questions. We provide an
example of the voting outcome, based on the iEtD out-
put and with the addition of the panel’s comments and
technical team’s annotations (Additional file 4). The
level of agreement was generally very good, but varied
slightly across questions and criteria; it was higher for
GQ (the highest) and Q1 compared with Q2 and Q3. Al-
though initially all the EtD criteria were judged relevant
for guideline development, the FOCUS panellists consid-
ered the existing evidence upon the criteria of resource
use and cost-effectiveness, as collected in the frame of
the FOCUS project, insufficient to use these criteria to
justify their recommendations (Additional file 5). Subse-
quently, the main point raised by the panel during the
discussion was the necessity to put more emphasis on
what had been learned from the qualitative evidence
base, and in particular from our realist review, which
combined qualitative and quantitative evidence [16].
This translated into a final version in which the sugges-
tions on how to implement interventions to increase the
chance of success were included in the core of the
guidelines, rather than only as additional considerations.
Finally, the attribute of ‘conditional’ for recommenda-
tions, as opposed to ‘strong’, was preferred over ‘weak’
to emphasise that the recommendation is conditional to
confirmation from further evidence and/or conditional
to implementing facilitators or overcoming barriers.
FOCUS guidelines and their justification
Table 3 presents the final FOCUS Recommendations (R)
on interventions to prevent or delay the progression of
frailty, or to reverse frailty, in response to the four ques-
tions, i.e. RG (‘G’ for general), R1, R2, and R3. Below, we
offer a justification, subgroup considerations and other
considerations related to monitoring and evaluation, for
each guideline. In Additional file 5 we provide a detailed
justification for the judgement on each criterion for each
guideline.
RG – We suggest implementing interventions spe-
cifically intended to have an impact on frailty in
older age, i.e. preventing or delaying the progression
of frailty or reversing frailty (conditional strength of
recommendation).
Justification. The recommendation stems from the belief,
common among different stakeholders and endorsed by theguideline panel, that frailty as an outcome is important and
that interventions explicitly conceived to address it are
needed. We found some quantitative evidence for different
interventions being associated with delaying the progres-
sion of frailty or reverting frailty, although the effects were
moderate in their size at maximum. These interventions,
based on either a mainly physical concept of frailty or on a
more comprehensive view, could be potentially fair, accept-
able and feasible from a population perspective. However,
the strength of this recommendation is weak/conditional
because of the low certainty/quality of the quantitative evi-
dence, due to substantial study limitations, inconsistency
and heterogeneity across studies (different populations, in-
terventions, outcome definition, and settings/contexts) as
well as imprecision of the estimates.
Subgroup considerations. The level or extent of frailty
was expected to act as an effect modifier of interventions
on frailty, i.e. affecting their relative effect, because of
several reasons. For instance, some interventions are ex-
pected to work only or more in the presence of a certain
deficit status. On the other hand, being frailer might
affect the opportunity to benefit from interventions that
either require an active participation or work only in less
severe illness states. In fact, among the studies examined
in our systematic review [11], those that found signifi-
cant benefits on frailty progression included participants
belonging to a range of levels of frailty and ages. It was
difficult to look at the effect of the level of frailty as a
predictor of an intervention to succeed since the hetero-
geneity across studies upon several aspects meant that
the role of the level of frailty could have been con-
founded by other possible predictors such as the level of
compliance or adherence to the intervention. Moreover,
even if some of the authors themselves supposed or per-
ceived there to be a window for the intervention to work
according to the level of frailty or disability of partici-
pants, this hypothesis was not systematically explored in
any study.
Considerations on monitoring and evaluation. The
panel judged the implementation of strategies to moni-
tor (and then improve) the adherence to the intervention
as important, in particular in the case of interventions
that require an active participation of the older person.
The need to implement an effective evaluation plan of
the interventions was also emphasised. In the FOCUS
project, we aimed to analyse the initiatives (i.e. commit-
ments or Good Practices) within the EIP-AHA [30] in
order to study the relationship between the outcomes of
these initiative and feasibility aspects (barriers and facili-
tators), resources and processes (Table 1). In this con-
text, we found that many initiatives were undertaken
without any plan for evaluation, e.g. assessment of their
Table 3 FOCUS guidelines
GQ – Should interventions to prevent or delay the progression of frailty, or to reverse frailty, be adopted in prefrail or frail older people?
Recommendation RG Conditions for the intervention to succeed [14]
We suggest implementing interventions specifically intended to
have an impact on frailty in older age, i.e. preventing or delaying
the progression of frailty, or reversing frailty (conditional strength
of recommendation)
Participant factors
• Co-create the details of interventions with intended recipient groups
• Consider the level of frailty of participants
• Employ best practice health psychology behaviour change strategies
• Consider group and fun, rewarding interventions wherever possible
• Determine whether the intervention is only appropriate if a specific
deficiency is present, e.g. nutritional deficiency
• Before implementing an intervention, consider correcting deficiencies
that can interact with the intervention’s working mechanisms
• Address understanding and attitudes towards malleability of frailty of
patients before the intervention
• Address self-efficacy in the intervention activity
• Consider accessibility of locations to individuals
• Employ approaches that are person, family and ‘lifeworld’ centred
• Include social and psychological wellbeing factors
Organisational factors
• Co-create the details of interventions with intended delivery practitioners
• Ensure training to emphasise implementation fidelity and standardisation
of delivery
• Address practitioners’ understanding and attitudes towards the malleability
of frailty before the intervention
• Consider expectations of older adults’ commitment and ability to participate
• Provide some training in health psychology components
Country/contextual/cultural factors
• Consider the suitability of the intervention for your context
(e.g. clinical, community, inpatient, outpatient)
• Consider likely cultural preferences, e.g. for expert-led or self-directed
interventions
• Consider what ‘normal care’ is in your context
• Consider the level of existing health literacy in your population
Q1 – Should physical interventions be recommended to prevent or delay the progression of frailty, or to reverse frailty, in prefrail or frail
older people?
Recommendation R1 Conditions for the intervention to succeed [14]
We suggest implementing physical interventions, including physical
activity/exercise, nutritional interventions, and a combination of
exercise and nutritional interventions, to prevent or delay the
progression of frailty, or to reverse frailty (conditional strength of
recommendation). The recommendation is stronger for group-based
supervised exercise programmes, either alone or in association with
nutritional supplementation
Among the factors to consider when an intervention on frailty is
implemented, those which are particularly relevant in the case of physical
interventions are:
• Consider implementing those factors that can increase participants’
acceptance of and, as a consequence, compliance to the intervention,
i.e. the inclusion of elements favouring or promoting socialisation, fun,
accessibility, self-efficacy and commitment. Among those factors,
consider the implementation of group-based exercise programmes and
supervision by professionals with adequate training; in general, include
professionals with adequate skills in health psychology and
communication; the inclusion of these elements might affect the
adherence to the intervention
• Consider the characteristics of the participants to whom the intervention
will be directed, for example, the presence of deficits that make the
intervention necessary, and the level of expected compliance. The level
of frailty particularly may have an important impact, not least because it is
likely to be associated with these other characteristics
• Even though physical interventions for physical components of frailty are
appropriate, considering the person as a whole, including, for example,
their psychological wellbeing and functions and their social context,
may be beneficial
• The opportunity to take into account and include these elements might
affect the feasibility and suitability of the interventions in each specific
context
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Table 3 FOCUS guidelines (Continued)
Q2 – Should interventions based on tailored care and/or GEM be recommended to prevent or delay the progression of frailty, or to
reverse frailty, in prefrail or frail older people?
Recommendation R2 Conditions for the intervention to succeed [14]
We suggest implementing interventions based on tailored care
and/or GEM, to prevent or delay the progression of frailty, or to
reverse frailty (conditional strength of recommendation).
The recommendation is stronger for GEM-based interventions
involving a multidisciplinary team, especially in inpatient clinical
settings, but still conditional to the confirmation from further
studies of good quality
Among the factors to consider when an intervention on frailty is
implemented, those of particular relevance to interventions aimed at a
more comprehensive concept of frailty:
• Consider the context (the clinical setting, usual care, cultural preferences)
• Co-create the details of interventions with intended delivery practitioners,
provide adequate training to ensure implementation fidelity
• Consider the inclusion of professionals with adequate skills
or provide training in health psychology and communication
• Employ approaches that are person, family and ‘lifeworld’ centred
Q3 – Should other interventions be recommended to prevent or delay the progression of frailty, or to reverse frailty, in prefrail or
frail older people?
Recommendation R3 Conditions for the intervention to succeed [14]
We suggest considering interventions to prevent or delay the
progression of frailty, or to revert frailty, based on cognitive training,
alone or in combination with exercise and nutritional supplementation
(conditional strength of recommendation), and on exercise combined
with diet consultation, at least in prefrail populations. At the moment,
the panel does not suggest adopting interventions based on hormone
therapy or on problem-solving therapy with the aim of preventing or
delaying the progression of frailty or of reverting frailty (conditional
strength of recommendation). Currently, there is no evidence in favour
or against other interventions potentially effective on frailty
(e.g. other types of psychological interventions, interventions mainly
focused on increasing socialisation, other types of hormone therapies
and pharmacological interventions).
Many of the factors described for the success of a physical intervention
(refer to Q1), or for interventions based on a patient-centred approach and
comprehensive care (refer to Q2), are also relevant to alternative interventions
described in Q3.
GQ general question; Q question; R recommendation
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and/or compared with the resources used. This limits
the opportunity to assess the transferability and scalabil-
ity of interventions, which is important from a popula-
tion perspective, and is one of the main objectives of the
EIP-AHA initiative of the European Commission.
R1 – We suggest implementing physical interven-
tions, including physical activity/exercise, nutritional
interventions, and a combination of exercise and nu-
tritional interventions, to prevent or delay the pro-
gression of frailty or to reverse frailty (conditional
strength of recommendation). The recommendation
is stronger for group-based supervised exercise pro-
grammes, either alone or in association with nutri-
tional supplementation.
Justification. We found quantitative evidence supporting
the success of physical interventions in delaying the pro-
gression of or revert frailty, especially when frailty was de-
fined according to a physical paradigm or measures of its
physical component. This component, according to older
people’s opinions collected through our qualitative studies
(Table 1), although partial, appears to have a compensa-
tory and synergistic relationship with other frailty compo-
nents such as psychological frailty. However, the strength
of this recommendation is weak because of the low cer-
tainty/quality of the quantitative evidence, due tosubstantial study limitations, inconsistency and heterogen-
eity (different populations and interventions) as well as
imprecision. Furthermore, the recommendation is meant
to be conditional to the presence of factors shown to affect
the acceptability and feasibility of such interventions and,
hence, their success (Table 3).
Subgroup considerations. Among the studies on phys-
ical interventions included in our systematic review [11],
those that found significant benefits for frailty progres-
sion included participants belonging to a range of sever-
ities of frailty and ages. This was true for the different
types of physical interventions considered here. On the
other hand, it was suggested that a deficit status was ne-
cessary for interventions based on nutritional supple-
mentation to effectively impact the level of frailty [31].
Even if some of the authors themselves supposed or
perceived there to be an intervention window for
physical transitions, this hypothesis was not systemat-
ically explored in any study. Additionally, without any
specific analysis, it was impossible to separate the role
of the severity of frailty on the effectiveness of the
intervention from other possible correlated predictors.
For example, in one study on exercise plus protein
supplementation it was clearly shown that the initial
level of frailty was associated with the level of compli-
ance to the intervention [32].
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on tailored care and/or Geriatric Evaluation and
Management (GEM), to prevent or delay the progres-
sion of frailty or to reverse frailty (conditional
strength of recommendation). The recommendation
is stronger for GEM-based interventions involving a
multidisciplinary team, especially in inpatient clinical
settings, but still conditional to the confirmation
from further studies of good quality.
Justification. We found some quantitative evidence for
interventions based on a tailored care concept and/or on
GEM being able to delay the progression of or revert
frailty, as defined according to either a mainly physical
paradigm or a multidomain paradigm. Some studies also
reported on the impact of these interventions on frailty-
related outcomes like functional ability, quality of life
and hospitalisation (Additional file 2). Involvement of
different professionals, a patient-centred approach, and
delivering the intervention at a convenient location and/
or in inpatient settings, seemed to be factors more likely
associated with successful interventions, even though
only limited head-to-head comparisons between inter-
ventions differing upon these aspects exist. Such types of
interventions and, in particular, the presence of those
factors, are also consistent with older people’s values
and preferences as well as policy-makers’ idea of the dir-
ection towards which health systems should go, as col-
lected through qualitative research [12–14] (Table 1).
However, quantitative findings were not consistent
across studies, even across similar studies, and studies
had several methodological pitfalls. Therefore, no strong
recommendations could be made.
Subgroup considerations. It was difficult to reliably
prove whether the level of frailty really acted as an effect
modifier since, within studies, no subgroup analyses
were systematically undertaken with this purpose. As a
matter of fact, most of the interventions of this category
that had positive significant effects on frailty were imple-
mented in frail rather than prefrail populations.
R3 – We suggest considering interventions to pre-
vent or delay the progression of frailty or to revert
frailty, based on cognitive training, alone or in com-
bination with exercise and nutritional supplementa-
tion (conditional strength of recommendation), and
on exercise combined with diet consultation, at least
in prefrail populations. At present, the panel does
not suggest adopting interventions based on hor-
mone therapy or on problem-solving therapy with
the aim of preventing or delaying the progression of
frailty or of reverting frailty (conditional strength of
recommendation). Currently, there is no evidence in
favour or against other interventions that couldpotentially be effective on frailty (e.g. other types of
psychological interventions, interventions mainly fo-
cused on increasing socialisation, other types of hor-
mone therapies, and pharmacological interventions).
Justification. Interventions included in this last question
were assessed separately because of their heterogeneity.
Only one study per intervention was available. The panel
judgment was mainly based on the quantitative results of
these single studies and their quality, along with consider-
ations regarding values, equity, acceptability and feasibility
that could apply to each intervention separately. Thus, the
evidence was judged as uncertain and the recommenda-
tions were made with weak strength, conditional to the
confirmation from further studies.
Subgroup considerations. All the studies relevant to this
question were performed on a population definable as pref-
rail; therefore, no subgroup considerations could be made.
Discussion
Strengths of our work
This paper presents evidence- and consensus-based clin-
ical guidelines on interventions to prevent or treat
frailty, developed in the context of the FOCUS project.
This was a core objective of the project, i.e. an ultimate
deliverable in which the quantitative and qualitative re-
search studies conducted in context of the project con-
verged, and also represented the content of the service
we intended to deliver in our proposal. To achieve such
a pivotal objective, we required a solid methodological
structure and the involvement of the entire FOCUS con-
sortium to act as the guideline panel. We developed four
guidelines based on one overarching question concern-
ing interventions for frailty in general and three sub-
questions on specific groups of interventions. Each
guideline includes a recommendation on whether and
how interventions should be implemented.
Our work has distinctive characteristics among other
initiatives that have been undertaken to help clinicians
and patients make informed decisions in the context of
frailty. For instance, in 2015, the EIP-AHA – Action
Group A3 produced a Decalogue on Frailty Prevention
as a result of the work conducted by the group in the
period 2012–2015, which includes ten key messages fo-
cusing on “the main areas of interest that policy makers
at Member State level would need to support in order to
tackle frailty” [33]. Before that, the British Geriatrics
Society, in association with the Royal College of
General Practitioners and Age UK, had published Fit
for Frail, a comprehensive best practice guidance docu-
ment for the care of older people living with frailty in
community and outpatient settings [34]. Both of these
initiatives are consensus-based guides that stemmed
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cieties’ members. Although these documents are useful
and translate knowledge into action, they either did not
start from a systematic appraisal of the evidence, or the
process and evidence was not clearly documented and
accessible. More recently, the results of a concurrent
initiative – the Asia-Pacific Clinical Practice Guidelines
for the Management of Frailty – have been published
[35]. Starting from the presentations and discussions at
the Asia-Pacific Geriatrics Conference on Geriatrics Be-
yond Borders: Are We Frailty Ready?, they performed a
comprehensive and systematic review and adopted the
GRADE approach to develop recommendations that
span many aspects of the management of frailty. Two
elements, inherent to the FOCUS mission, distinguish
ours from these guidelines. First, we had the opportun-
ity to use both quantitative and qualitative evidence in
order to combine effect sizes with relevant stake-
holders’ inputs and perspectives in the development of
our guidelines, according to an integrated knowledge
translation strategy. For these reasons, we adopted the
EtD framework proposed by the GRADE working
group, i.e. because of the relevance given to perspec-
tives and subgroups, and the value assigned to criteria
like values, acceptability, feasibility and equity.
Secondly, not only did we have a narrower and deeper
focus on interventions only, but we specifically
reviewed and based our recommendations on interven-
tional studies that explicitly looked at frailty as an out-
come, excluding those studies in which interventions
were applied to people with or at risk of frailty but
assessed upon different outcomes. Although this may
have led to the inclusion of a narrower evidence base,
our approach intended to give frailty the dignity of a
condition. Indeed, the role of frailty as a measurable
outcome, and not only as a predictor, to evaluate the
impact of interventions or of other types of exposures,
has been increasingly recognised in different clinical
settings [36, 37]. At the same time, within the selected
studies, we did consider other outcomes, thus not over-
looking or undervaluing the possibility that interven-
tions can impact other important adverse events to
which frail people are vulnerable.
Limitations
Our work has recognised limitations. The main limitation
to the production of definitive guidelines was related to the
quantitative evidence base. The evidence available was of
low quality due to methodological bias, inconsistencies and
imprecision in the existing studies. In addition to the low
quality of the collected evidence, there was a high level of
methodological heterogeneity, which had already prevented
any quantitative synthesis in our systematic review [11].
The diversity of frailty definitions and operationalisationswas mostly expected. It is also possible that our choice to
include studies in our systematic review in which authors
operationalised frailty using a study-specific, pre-specified
set of indicators, while valuing the intention of the investi-
gators, increased such heterogeneity. As a result of the het-
erogeneity and low quality of the collected evidence, which
was often coupled with inadequate reporting, we were not
able to draw the typical GRADE summary of findings or
evidence profile tables [25]. The heterogeneous nature of
interventions also represented a challenge to framing the
guidelines into questions and grouping the interventions in
an appropriate but also user-friendly manner. Finally, we
encountered some technical limitations. Firstly, there were
time constraints dictated by the FOCUS project timeline,
which impeded the possibility of arranging a conference to
facilitate the panel discussion. However, the discussion that
took place online and by email achieved satisfactory results.
Secondly, although extremely useful and user friendly, the
EtD tool was limited in terms of flexibility to the develop-
ment of guidelines for heterogeneous interventions in a
field of complex nosography such as frailty in older age.
Lessons learned and future directions
The ultimate lesson we learned with our 3-year work is
that, while stakeholders showed awareness of and place
relevance to the challenge represented by age-related
frailty, the current scientific quantitative evidence still has
important limitations. This was reflected in our guidelines,
which could include only weak or conditional recommen-
dations. Even if such types of recommendations might
seem less appealing or helpful, they do yield an important
message to the clinician and decision-maker, i.e. to be
considered when these interventions are adopted, or in-
deed, to give consideration to when and whether to adopt
them. This message reflects the limitations of the scientific
literature and important implementation considerations.
Our work also conveys an important lesson to the re-
searcher – while the evidence heterogeneity could never
be eliminated since it reflects the heterogeneity in the def-
inition of frailty itself, we need more studies which specif-
ically recognise and measure frailty as an outcome as well
as greater adherence to high methodological standards.
This is true in general, but in particular for studies on
comprehensive frailty interventions, which have the po-
tential to be effective, especially when defined holistically,
and have so far not been adequately evaluated. We also
need more studies to compare different interventions. The
fact that most of the studies included in our evidence base
compared the experimental intervention with ‘usual prac-
tice’, which can differ dramatically from reality to reality,
made the findings extremely context bound. This gener-
ated the need to include, in our guidelines, not only an
answer to the question ‘does it work?’ but also a consider-
ation of the circumstances of success.
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Herein, we delivered evidence- and consensus-based
guidelines on interventions that can affect frailty as
an outcome. We recognised that these are not con-
clusive; rather, they should foster further studies, both
on those interventions already investigated in the lit-
erature but requiring higher research standards as
well as on potentially effective interventions that have
not been appropriately studied thus far. On the other
hand, our recommendations should start informing
practices. In the context of the FOCUS project, we
ended our project by testing the feasibility and impact
of our guidelines when used to inform clinical deci-
sions and help implement or refine interventions ad-
dressing frailty as a patient-important outcome; the
results of these proof-of-concept pilots are currently
in preparation for publication [38].
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